Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma
Authors:
- T. IuchiT. Iuchi
- M. ShingyojiMSM. Shingyoji
- T. SakaidaTST. Sakaida
- K. HatanoKHK. Hatano
- O. NaganoONO. Nagano
- M. ItakuraMIM. Itakura
- H. KageyamaHKH. Kageyama
- S. YokoiSYS. Yokoi
- Y. HasegawaYHY. Hasegawa
- K. KawasakiKKK. Kawasaki
- T. IizasaTIT. Iizasa
- 1 November 2013
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 82 (2) , 282-287
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 StudyJournal of Clinical Oncology, 2011
- Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active EffluxThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 PatientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialThe Lancet Oncology, 2009
- Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLCBritish Journal of Cancer, 2008
- Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole‐brain radiotherapy administered firstCancer, 2008
- Up‐front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastasesCancer, 2007
- Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or ErlotinibClinical Cancer Research, 2006
- Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or ErlotinibClinical Cancer Research, 2006
- The Use of the Mini-Mental State Examination to Assess Cognitive Functioning in Cancer Trials: No Ifs, Ands, Buts, or SensitivityJournal of Clinical Oncology, 2003